多祖先全基因组关联研究揭示主动脉瓣狭窄多个新基因位点
研究识别出23个全基因组显著领先变异,代表17个独特基因组区域,其中14个变异在重复验证中显著,对应11个区域,包括6个新位点。孟德尔随机化提示脂蛋白(a)和低密度脂蛋白胆固醇与CAS相关。
要点
- 在百万退伍军人计划中识别出6个CAS新基因组区域。
- 仅2个重复验证变异(LPA和CELSR2)与动脉粥样硬化性心血管疾病共享。
- 脂蛋白(a)与CAS的关联强于低密度脂蛋白胆固醇。
核心结论
- 在百万退伍军人计划中识别出6个CAS新基因组区域,提示脂质代谢、炎症、细胞衰老和肥胖在CAS病理生物学中的作用。
主要发现
- GWAS识别出23个全基因组显著领先变异,代表17个独特基因组区域。
- 23个领先变异中14个在重复验证中显著,代表11个独特基因组区域。
- 5个重复验证区域为已知CAS风险位点(PALMD、TEX41、IL6、LPA、FADS),6个为新位点(CEP85L、FTO、SLMAP、CELSR2、MECOM、CDAN1)。
- 两个新领先变异在非白人个体中相关(P<0.05):rs12740374(CELSR2)在黑人和西班牙裔个体中,rs1522387(SLMAP)在黑人个体中。
- 14个重复验证领先变异中仅2个(rs10455872 [LPA]、rs12740374 [CELSR2])在动脉粥样硬化性心血管疾病GWAS中也显著。
关键数值与推荐
- 孟德尔随机化显示脂蛋白(a)和低密度脂蛋白胆固醇均与CAS相关,但调整脂蛋白(a)后低密度脂蛋白胆固醇与CAS的关联减弱。
- Phenome-wide association study显示不同程度的多效性,包括FTO位点与肥胖的关联;调整体重指数后FTO位点仍与CAS相关,中介分析中保持独立显著效应。
临床怎么用
- 研究结果可能有助于优先筛选CAS的治疗靶点,并强调脂蛋白(a)在CAS风险中的潜在重要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Calcific aortic stenosis (CAS) is the most common valvular heart disease in older adults and has no effective preventive therapies. Genome-wide association studies (GWAS) can identify genes influencing disease and may help prioritize therapeutic targets for CAS. METHODS: We performed a GWAS and gene association study of 14 451 patients with CAS and 398 544 controls in the Million Veteran Program. Replication was performed in the Million Veteran Program, Penn Medicine Biobank, Mass General Brigham Biobank, BioVU, and BioMe, totaling 12 889 cases and 348 094 controls. Causal genes were prioritized from genome-wide significant variants using polygenic priority score gene localization, expression quantitative trait locus colocalization, and nearest gene methods. CAS genetic architecture was compared with that of atherosclerotic cardiovascular disease. Causal inference for cardiometabolic biomarkers in CAS was performed using Mendelian randomization and genome-wide significant loci were characterized further through phenome-wide association study. RESULTS: We identified 23 genome-wide significant lead variants in our GWAS representing 17 unique genomic regions. Of the 23 lead variants, 14 were significant in replication, representing 11 unique genomic regions. Five replicated genomic regions were previously known risk loci for CAS (PALMD, TEX41, IL6, LPA, FADS) and 6 were novel (CEP85L, FTO, SLMAP, CELSR2, MECOM, CDAN1). Two novel lead variants were associated in non-White individuals (P<0.05): rs12740374 (CELSR2) in Black and Hispanic individuals and rs1522387 (SLMAP) in Black individuals. Of the 14 replicated lead variants, only 2 (rs10455872 [LPA], rs12740374 [CELSR2]) were also significant in atherosclerotic cardiovascular disease GWAS. In Mendelian randomization, lipoprotein(a) and low-density lipoprotein cholesterol were both associated with CAS, but the association between low-density lipoprotein cholesterol and CAS was attenuated when adjusting for lipoprotein(a). Phenome-wide association study highlighted varying degrees of pleiotropy, including between CAS and obesity at the FTO locus. However, the FTO locus remained associated with CAS after adjusting for body mass index and maintained a significant independent effect on CAS in mediation analysis. CONCLUSIONS: We performed a multiancestry GWAS in CAS and identified 6 novel genomic regions in the disease. Secondary analyses highlighted the roles of lipid metabolism, inflammation, cellular senescence, and adiposity in the pathobiology of CAS and clarified the shared and differential genetic architectures of CAS with atherosclerotic cardiovascular diseases.
引用
- Small AM, Peloso GM, Linefsky J, et al. Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran Program. Circulation. 2023. PMID: 36802703. doi:10.1161/CIRCULATIONAHA.122.061451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。